SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-060796
Filing Date
2024-05-16
Accepted
2024-05-16 07:30:21
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-16

Document Format Files

Seq Description Document Type Size
1 ARS 2023_annual_report.pdf ARS 4138387
  Complete submission text file 0000950170-24-060796.txt   5701473
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39856 | Film No.: 24953563
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)